Prospective cohort study to examine exacerbation frequency and risk factors for joint symptoms related to postoperative endocrine treatment in breast cancer patients

Prospective cohort study to examine exacerbation frequency and risk factors for joint symptoms related to postoperative endocrine treatment in breast cancer patients - Prospective cohort study on joint symptoms by postoperative endocrine treatment

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000030099

Enrollment

300

Registered

2018-01-25

Start date

2018-01-25

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hormone-receptor-positive breast cancer

Interventions

None listed

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1.Estrogen receptor positive primary breast cancer patients 2.Patients who start postoperative endocrine treatment

Exclusion criteria

Exclusion criteria: Patients judged inappropriate by doctors

Design outcomes

Primary

Measure	Time frame
Exacerbation rate of joint symptoms for 1 year after starting endocrine treatment	—

Countries

Japan

Contacts

Public ContactNaruto Taira

Okayama University Hospital Breast and Endocrine Surgery

ntaira@md.okayama-u.ac.jp086-235-7265

Outcome results